KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Sales (2016 - 2025)

Regeneron Pharmaceuticals has reported Return on Sales over the past 17 years, most recently at 0.22% for Q4 2025.

  • Quarterly results put Return on Sales at 0.22% for Q4 2025, down 2.0% from a year ago — trailing twelve months through Dec 2025 was 0.31% (changed 0.0% YoY), and the annual figure for FY2025 was 0.31%, changed 0.0%.
  • Return on Sales for Q4 2025 was 0.22% at Regeneron Pharmaceuticals, down from 0.39% in the prior quarter.
  • Over the last five years, Return on Sales for REGN hit a ceiling of 19.47% in Q1 2022 and a floor of 0.22% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.37% (2025), compared with a mean of 3.12%.
  • Biggest five-year swings in Return on Sales: surged 1903bps in 2022 and later tumbled -1921bps in 2023.
  • Regeneron Pharmaceuticals' Return on Sales stood at 18.58% in 2021, then dropped by -1bps to 18.42% in 2022, then tumbled by -98bps to 0.34% in 2023, then dropped by -28bps to 0.24% in 2024, then fell by -10bps to 0.22% in 2025.
  • The last three reported values for Return on Sales were 0.22% (Q4 2025), 0.39% (Q3 2025), and 0.38% (Q2 2025) per Business Quant data.